News , Products

BI’s NexGard will be made in Puerto Rico

A plant expansion will supply the North American market with the canine drug NexGard.

BI’s NexGard will be made in Puerto Rico

Boehringer Ingelheim will manufacture the flea and tick preventive NexGard (afoxolaner) in Puerto Rico upon expansion of a plant in the northern city of Barceloneta.

The $50 million project will lead to 105 additional full-time jobs at the factory, which now employs about 200 people.

Boehringer Ingelheim Animal Health in recent years has expanded vaccine and drug factories in Georgia and Missouri.

The 48-year-old Puerto Rico plant now manufactures the heartworm preventive Heartgard Plus (ivermectin/pyrantel) and packages Brazilian-made NexGard chewables for shipment to the United States and Canada.

Drug manufacturing is a leading industry on the island, making up 29.9% of the U.S. territory’s gross domestic product, a government official said.

Boehringer Ingelheim also announced the donation of 60,000 doses of rabies vaccine “and tens of thousands of dollars” to fight rabies in Puerto Rico. Protection Status